Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
BW-00112 by Shanghai Argo Pharmaceutical for Hypertriglyceridemia: Likelihood of Approval
BW-00112 is under clinical development by Shanghai Argo Pharmaceutical and currently in Phase II for Hypertriglyceridemia. According to GlobalData, Phase...